retatrutide type 2 diabetes trial nct A new clinical from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and 💉 A triple-action once-weekly injection

This rapid growth underscores the increasing adoption of GLP-1 receptor agonists for type 2 diabetes management, driven by their efficacy in glycemic control, weight reduction, and cardiovascular risk mitigation

They slow gastric emptying, which contributes to a longer sensation of fullness and reduces food intake

Patients with type 2 diabetes who struggle with blood sugar control and weight management are ideal candidates for this combination therapy

Could there be any less sexy ingredient than Vitamin C yet one thats more beneficial to your skin

If hiccups or other gastrointestinal symptoms are affecting your GLP-1 treatment experience, sharing your genetic test results with your provider can support a more informed discussion about dose timing, dietary adjustments, or whether an alternative peptide compound might offer better tolerability while maintaining your health goals